JAMA Network Home
Sign In
Research Summary

Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes

JAMA 10.1001/jama.2026.3429

March 28, 2026 at 4:45 PM EDT

Read the full article

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.3429?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032826

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks